Comerica Bank Rocket Pharmaceuticals, Inc. Transaction History

Comerica Bank

$25 Billion
Q3 2024

A detailed history of Comerica Bank transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Comerica Bank holds 785,526 shares of RCKT stock, worth $11.3 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

785,526

Previous 686,654 14.4%

Holding current value

$11.3 Million

Previous $14.8 Million 1.86%

% of portfolio

0.06%

Previous 0.06%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$17.6 - $25.88 $1.74 Million - $2.56 Million	98,872 Added 14.4%	785,526 $14.5 Million
Q2 2024 Aug 15, 2024	BUY	$20.66 - $26.72 $3.14 Million - $4.06 Million	152,129 Added 28.46%	686,654 $14.8 Million
Q1 2024 May 15, 2024	SELL	$26.16 - $30.74 $614,760 - $722,390	-23,500 Reduced 4.21%	534,525 $14.4 Million
Q4 2023 Feb 14, 2024	BUY	$16.78 - $31.94 $1.98 Million - $3.77 Million	117,949 Added 26.8%	558,025 $16.7 Million
Q3 2023 Nov 21, 2023	BUY	$15.07 - $24.05 $6.63 Million - $10.6 Million	440,076 New	440,076 $9.02 Million
Q4 2022 Jan 26, 2023	BUY	$15.5 - $22.76 $616,993 - $905,984	39,806 Added 16.02%	288,316 $0
Q3 2022 Oct 28, 2022	BUY	$12.37 - $18.41 $618 - $920	50 Added 0.02%	248,510 $4.07 Million
Q2 2022 Aug 02, 2022	BUY	$7.96 - $16.64 $927,363 - $1.94 Million	116,503 Added 88.29%	248,460 $4.15 Million
Q1 2022 Apr 27, 2022	BUY	$13.16 - $23.68 $38,690 - $69,619	2,940 Added 2.28%	131,957 $2.09 Million
Q4 2021 Feb 18, 2022	BUY	$21.52 - $36.02 $275,176 - $460,587	12,787 Added 11.0%	129,017 $2.82 Million
Q3 2021 Nov 22, 2021	SELL	$27.42 - $48.97 $108,638 - $194,019	-3,962 Reduced 3.3%	116,230 $3.47 Million
Q2 2021 Aug 26, 2021	BUY	$39.41 - $47.25 $1.56 Million - $1.87 Million	39,487 Added 48.93%	120,192 $5.32 Million
Q1 2021 Apr 28, 2021	BUY	$43.34 - $65.91 $1.08 Million - $1.64 Million	24,894 Added 44.6%	80,705 $3.58 Million
Q4 2020 Jan 28, 2021	BUY	$23.3 - $59.57 $621,294 - $1.59 Million	26,665 Added 91.49%	55,811 $3.06 Million
Q3 2020 Oct 30, 2020	BUY	$20.5 - $28.59 $67,240 - $93,775	3,280 Added 12.68%	29,146 $666,000
Q2 2020 Jul 31, 2020	SELL	$13.32 - $22.61 $70,396 - $119,493	-5,285 Reduced 16.97%	25,866 $541,000
Q1 2020 May 01, 2020	BUY	$9.71 - $25.11 $39,675 - $102,599	4,086 Added 15.1%	31,151 $434,000
Q4 2019 Feb 07, 2020	SELL	$11.07 - $24.23 $12,066 - $26,410	-1,090 Reduced 3.87%	27,065 $615,000
Q3 2019 Oct 31, 2019	BUY	$10.85 - $14.78 $79,519 - $108,322	7,329 Added 35.19%	28,155 $328,000
Q2 2019 Aug 02, 2019	BUY	$15.0 - $19.81 $312,390 - $412,563	20,826 New	20,826 $0

Others Institutions Holding RCKT

# of Institutions

209

Shares Held

93.2M

Call Options Held

319K

Put Options Held

70.3K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $1.09B
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.

Account